These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1157 related articles for article (PubMed ID: 26817523)

  • 41. Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol.
    Hill M; Wright D; Daley R; Lewis C; McKay F; Mason S; Lench N; Howarth A; Boustred C; Lo K; Plagnol V; Spencer K; Fisher J; Kroese M; Morris S; Chitty LS
    BMC Pregnancy Childbirth; 2014 Jul; 14():229. PubMed ID: 25027965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Retrospective analysis of cell-free fetal DNA prenatal testing of maternal peripheral blood].
    Wei Y; Wang R; Xi M; Wei L; Zhu W; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):933-938. PubMed ID: 37532491
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing.
    Nicolaides KH; Syngelaki A; Poon LC; Gil MM; Wright D
    Fetal Diagn Ther; 2014; 35(3):185-92. PubMed ID: 24192489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of first trimester screening and early fetal anomaly scan on invasive testing rates in women with advanced maternal age.
    Hagen A; Entezami M; Gasiorek-Wiens A; Albig M; Becker R; Knoll U; Stumm M; Wegner RD
    Ultraschall Med; 2011 Jun; 32(3):302-6. PubMed ID: 20972947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pregnancy outcome of autosomal aneuploidies other than common trisomies detected by noninvasive prenatal testing in routine clinical practice.
    Wan J; Li R; Zhang Y; Jing X; Yu Q; Li F; Li Y; Zhang L; Yi C; Li J; Li D; Liao C
    Prenat Diagn; 2018 Oct; 38(11):849-857. PubMed ID: 30078205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Noninvasive prenatal testing (NIPT) in twin pregnancies with treatment of assisted reproductive techniques (ART) in a single center.
    Tan Y; Gao Y; Lin G; Fu M; Li X; Yin X; Du J; Li J; Li W; Peng H; Yuan Y; Chen F; Jiang F; Zhang H; Lu G; Gong F; Wang W
    Prenat Diagn; 2016 Jul; 36(7):672-9. PubMed ID: 27150972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The potential impact of NIPT as a second-tier screen on the outcomes of high-risk pregnancies with rare chromosomal abnormalities.
    Maxwell S; Dickinson JE; Murch A; O'Leary P
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):420-6. PubMed ID: 26286670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient choice and clinical outcomes following positive noninvasive prenatal screening for aneuploidy with cell-free DNA (cfDNA).
    Dobson LJ; Reiff ES; Little SE; Wilkins-Haug L; Bromley B
    Prenat Diagn; 2016 May; 36(5):456-62. PubMed ID: 26938930
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(4):1-166. PubMed ID: 30847010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
    Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved diagnostic accuracy by using secondary ultrasound markers in the first-trimester screening for trisomies 21, 18 and 13 and Turner syndrome.
    Karadzov-Orlic N; Egic A; Milovanovic Z; Marinkovic M; Damnjanovic-Pazin B; Lukic R; Joksic I; Curkovic A; Mikovic Z
    Prenat Diagn; 2012 Jul; 32(7):638-43. PubMed ID: 22570267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The value of combined detailed first-trimester ultrasound-biochemical analysis for screening fetal aneuploidy in the era of non-invasive prenatal testing.
    Ye C; Duan H; Liu M; Liu J; Xiang J; Yin Y; Zhou Q; Yang D; Yan R; Li R
    Arch Gynecol Obstet; 2024 Aug; 310(2):843-853. PubMed ID: 37938359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aneuploidy screening by non-invasive prenatal testing in twin pregnancy.
    Fosler L; Winters P; Jones KW; Curnow KJ; Sehnert AJ; Bhatt S; Platt LD
    Ultrasound Obstet Gynecol; 2017 Apr; 49(4):470-477. PubMed ID: 27194226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening of fetal chromosomal aneuploidy diseases using noninvasive prenatal testing in twin pregnancies.
    Yu W; Lv Y; Yin S; Liu H; Li X; Liang B; Kong L; Liu C
    Expert Rev Mol Diagn; 2019 Feb; 19(2):189-196. PubMed ID: 30582381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ethical and practical challenges in providing noninvasive prenatal testing for chromosome abnormalities: an update.
    Benn P; Chapman AR
    Curr Opin Obstet Gynecol; 2016 Apr; 28(2):119-24. PubMed ID: 26938150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-invasive prenatal testing (NIPT): Europe's first multicenter post-market clinical follow-up study validating the quality in clinical routine.
    Flöck A; Tu NC; Rüland A; Holzgreve W; Gembruch U; Geipel A
    Arch Gynecol Obstet; 2017 Nov; 296(5):923-928. PubMed ID: 28887622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytogenomic results following high-chance non-invasive prenatal testing: a UK national audit.
    Togneri FS; Allen SK; Mann K; Holgado E; Morgan S
    Genet Res (Camb); 2020 Sep; 102():e7. PubMed ID: 32867862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Noninvasive prenatal screening for aneuploidy: positive predictive values based on cytogenetic findings.
    Meck JM; Kramer Dugan E; Matyakhina L; Aviram A; Trunca C; Pineda-Alvarez D; Aradhya S; Klein RT; Cherry AM
    Am J Obstet Gynecol; 2015 Aug; 213(2):214.e1-5. PubMed ID: 25843063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies.
    Hu H; Wang L; Wu J; Zhou P; Fu J; Sun J; Cai W; Liu H; Yang Y
    Hum Genomics; 2019 Mar; 13(1):14. PubMed ID: 30871627
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Accuracy of first-trimester combined test in screening for trisomies 21, 18 and 13.
    Santorum M; Wright D; Syngelaki A; Karagioti N; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Jun; 49(6):714-720. PubMed ID: 27549925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.